Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeffrey P Callen

Showing results (1-10 of 169) with videos related to

Pageof 17
Sort By:
Archives of Dermatology|June 20, 2002
When and how should the patient with dermatomyositis or amyopathic dermatomyositis be assessed for possible cancer?Jeffrey P Callen
Diseases of the Colon and Rectum|June 5, 2020
Expert Commentary on the Management of Peristomal Pyoderma Gangrenosum in a Patient With IBDJeffrey P Callen
The British Journal of Dermatology|July 28, 2012
Consider drugs as a cause or an exacerbating factor in patients diagnosed with subacute cutaneous lupus erythematosus!Jeffrey P Callen
Dermatologic Clinics|August 13, 2002
Neutrophilic dermatosesJeffrey P Callen
Archives of Dermatology|November 23, 2011
Practice Gaps. Optimizing antimalarial therapy for cutaneous lupus erythematosus: comment on "Response to antimalarial agents in cutaneous lupus erythematosus"Jeffrey P Callen
Best Practice & Research. Clinical Rheumatology|June 4, 2002
Management of skin disease in patients with lupus erythematosusJeffrey P Callen
Clinics in Dermatology|September 24, 2005
An approach to the patient with a recalcitrant dermatosisJeffrey P Callen
The Australasian Journal of Dermatology|January 13, 2006
Cutaneous lupus erythematosus: a personal approach to managementJeffrey P Callen
JAMA Dermatology|July 5, 2023
DermatomyositisJeffrey P Callen
JAMA Dermatology|July 12, 2013
Drug-induced subacute cutaneous lupus erythematosus--filling the gap in knowledge: comment on "subacute cutaneous lupus erythematosus induced by chemotherapy"Jeffrey P Callen
Pageof 17

Showing results (1-10 of 169) with videos related to

Sort By:
Pageof 17
Archives of Dermatology|June 20, 2002
When and how should the patient with dermatomyositis or amyopathic dermatomyositis be assessed for possible cancer?Jeffrey P Callen
Diseases of the Colon and Rectum|June 5, 2020
Expert Commentary on the Management of Peristomal Pyoderma Gangrenosum in a Patient With IBDJeffrey P Callen
The British Journal of Dermatology|July 28, 2012
Consider drugs as a cause or an exacerbating factor in patients diagnosed with subacute cutaneous lupus erythematosus!Jeffrey P Callen
Dermatologic Clinics|August 13, 2002
Neutrophilic dermatosesJeffrey P Callen
Archives of Dermatology|November 23, 2011
Practice Gaps. Optimizing antimalarial therapy for cutaneous lupus erythematosus: comment on "Response to antimalarial agents in cutaneous lupus erythematosus"Jeffrey P Callen
Best Practice & Research. Clinical Rheumatology|June 4, 2002
Management of skin disease in patients with lupus erythematosusJeffrey P Callen
Clinics in Dermatology|September 24, 2005
An approach to the patient with a recalcitrant dermatosisJeffrey P Callen
The Australasian Journal of Dermatology|January 13, 2006
Cutaneous lupus erythematosus: a personal approach to managementJeffrey P Callen
JAMA Dermatology|July 5, 2023
DermatomyositisJeffrey P Callen
JAMA Dermatology|July 12, 2013
Drug-induced subacute cutaneous lupus erythematosus--filling the gap in knowledge: comment on "subacute cutaneous lupus erythematosus induced by chemotherapy"Jeffrey P Callen
Pageof 17